Buy Miragen Therapeutics Stock | MGEN Stock Price & Latest News | Public.com
MGEN

Miragen Therapeutics

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Miragen Therapeutics (MGEN) stock trends here

    About MGEN

    Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lympho...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.64
    -1.27
    -1.91
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$1.91

    Actual EPS
    Q1 2021

    Stats

    Market Cap$70,26M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$25.67
    1 Year Low$4.67
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app